NCT06996080Phase 3Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Study sponsor: Kodiak Sciences Inc · KOD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-02Estimated
Enrollment · participants300Estimated
Source updated2026-05-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment increased by 150 participants

Before: 150 participants (planned). After: 300 participants (planned).

Primary completion date changed

Before: Dec 2026. After: Feb 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview